Cardinal Health Inc. (CAH) financials: revenue, earnings and cash flow
Fiscal 2017–2026 + TTM · from SEC filings · data as of November 13, 2026
Summary
Cardinal Health’s revenue went from $130.0B in fiscal 2017 to $254.2B in fiscal 2026, growth of about 7.7% a year.
Net income in fiscal 2026 was $1.7B, a net margin of 0.7%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $257.8B and net income $1.8B.
Free cash flow was $4.5B in fiscal 2026 and positive in 10 of the 10 years shown.
The diluted share count fell 26% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $257.8B | $254.2B | $222.6B | $226.8B | $205.0B | $181.3B | $162.5B | $152.9B | $145.5B | $136.8B | $130.0B |
| Gross profit | $10.1B | $9.8B | $8.2B | $7.4B | $6.9B | $6.5B | $6.8B | $6.9B | $6.8B | $7.2B | $6.5B |
| Operating income | $2.7B | $2.6B | $2.3B | $1.2B | $752M | -$607M | $472M | -$4.1B | $2.1B | $126M | $2.1B |
| Net income | $1.8B | $1.7B | $1.6B | $852M | $330M | -$938M | $611M | -$3.7B | $1.4B | $256M | $1.3B |
| EPS (diluted) | $7.73 | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +14.2% | −1.9% | +10.7% | +13.0% | +11.6% | +6.2% | +5.1% | +6.4% | +5.3% | +6.9% |
Cash flow
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.6B | $5.2B | $2.4B | $3.8B | $2.8B | $3.2B | $2.4B | $2.0B | $2.7B | $2.8B | $1.2B |
| Capital spending | -$698M | -$649M | -$547M | -$511M | -$481M | -$387M | -$400M | -$375M | -$328M | -$384M | -$387M |
| Free cash flow | $4.9B | $4.5B | $1.9B | $3.3B | $2.4B | $2.8B | $2.0B | $1.6B | $2.4B | $2.4B | $797M |
| Dividends paid | $488M | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M |
| Buybacks | $1.5B | $1.4B | $765M | $750M | $2.0B | $1.0B | $200M | $350M | $600M | $550M | $600M |
| Stock-based pay | $383M | $367M | $244M | $121M | $96M | $81M | $89M | $90M | $82M | $85M | $96M |
Balance sheet
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $4.9B | $3.9B | $5.3B | $4.1B | $4.7B | $3.4B | $2.8B | $2.5B | $1.8B | $6.9B |
| Debt | — | $9.9B | $9.3B | $5.6B | $5.2B | $5.8B | $6.7B | $7.2B | $8.0B | $9.0B | $10.4B |
| Equity | — | -$2.9B | -$2.8B | -$3.2B | -$3.0B | -$709M | $1.8B | $1.8B | $6.3B | $6.1B | $6.8B |
| Total assets | — | $57.3B | $53.1B | $45.1B | $43.3B | $43.9B | $44.5B | $40.8B | $41.0B | $40.0B | $40.1B |
| Shares (diluted) | 233M | 237M | 242M | 247M | 262M | 279M | 294M | 293M | 301M | 315M | 320M |
Margins and returns
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 3.9% | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% |
| Operating margin | 1.0% | 1.0% | 1.0% | 0.5% | 0.4% | -0.3% | 0.3% | -2.7% | 1.4% | 0.1% | 1.6% |
| Net margin | 0.7% | 0.7% | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% | -2.4% | 0.9% | 0.2% | 1.0% |
| FCF margin | 1.9% | 1.8% | 0.8% | 1.4% | 1.1% | 1.5% | 1.2% | 1.0% | 1.6% | 1.7% | 0.6% |
| ROIC | — | 29.0% | 25.9% | 36.9% | 26.8% | -9.4% | 4.4% | -44.5% | 11.2% | 0.7% | 8.3% |
| ROE | — | -59.5% | -56.1% | -26.5% | -11.2% | 132.3% | 34.1% | -206.6% | 21.5% | 4.2% | 18.9% |
Frequently asked questions
What is Cardinal Health’s annual revenue?
$254.2B in fiscal 2026 and $257.8B over the twelve months to September 30, 2026.
How much profit does Cardinal Health make?
Net income was $1.7B in fiscal 2026 (net margin 0.7%).
Is Cardinal Health’s revenue growing?
Yes: revenue rose 14.2% in fiscal 2026 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.